ZVRA
#2712
Zevra Therapeutics, Inc. - Common Stock
11.8 5 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.94%
Monthly Change
+21.91%
6 month change
+35.58%
Year Change
+11.37%
Previous Close
11.7 4
Open
11.8 5
Low
11.8 5
High
11.8 5
Volume
61
Financials
- Market Capitalization 703.7 M
- Employee 61
- Founded 2006
- CEO N/A
- Website www.zevra.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG1F5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
6.64
Price to sales ratio
4.82
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2699 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 36.70 USD | +2.03% | +0.77% | +23.03% | +113.99% | 717.46 M USD | ||
| 2707 |  ASMB Assembly Biosciences, Inc. - Common Stock | 34.80 USD | -1.75% | +2.78% | +35.15% | +18.27% | 708.55 M USD | ||
| 2725 |  HELP Cybin Inc. - Common Stock | 13.24 USD | -2.86% | +5.25% | +74.67% | +47.60% | 683.61 M USD | ||
| 2742 |  VSTM Verastem, Inc. - Common Stock | 7.38 USD | -0.14% | +7.27% | +18.27% | -20.30% | 668.36 M USD |
Frequently asked questions about Zevra Therapeutics, Inc. Common Stock
What is the Zevra Therapeutics, Inc. Common Stock stock price today?
The current price of Zevra Therapeutics, Inc. Common Stock (ZVRA) is 11.85. Over the past 24 hours, the stock has changed by +0.94%. Follow the ZVRA chart for real-time price dynamics.
What is the stock ticker of Zevra Therapeutics, Inc. Common Stock?
Zevra Therapeutics, Inc. Common Stock trades under the ticker ZVRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zevra Therapeutics, Inc. Common Stock stock going up?
ZVRA has changed by -0.84% over the last week, +21.91% over the last month, and +11.37% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Zevra Therapeutics, Inc. Common Stock?
Zevra Therapeutics, Inc. Common Stock currently has a market capitalization of 703.7 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Zevra Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Zevra Therapeutics, Inc. Common Stock reported earnings of 0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Zevra Therapeutics, Inc. Common Stock revenue for the last quarter?
Zevra Therapeutics, Inc. Common Stock reported quarterly revenue of 39.66 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Zevra Therapeutics, Inc. Common Stock net income for the last quarter?
Zevra Therapeutics, Inc. Common Stock reported net income of 8.75 M for the last quarter. The previous quarter showed 37.89 M, which means net income changed by -76.90%.
How many employees does Zevra Therapeutics, Inc. Common Stock have?
As of the latest available data, Zevra Therapeutics, Inc. Common Stock has 61 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zevra Therapeutics, Inc. Common Stock EBITDA?
Zevra Therapeutics, Inc. Common Stock EBITDA is 18.98 M, and its EBITDA margin is 47.86%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zevra Therapeutics, Inc. Common Stock stock?
You can buy Zevra Therapeutics, Inc. Common Stock (ZVRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zevra Therapeutics, Inc. Common Stock stock?
Investing in Zevra Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZVRA chart and related analysis on metatrader.com as part of your research.